Smoking Cessation in Alcoholism Treatment

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

112 participants

Study Classification

INTERVENTIONAL

Study Completion Date

2002-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is designed to increase understanding of the processes that affect the treatment outcome of individuals with both alcohol and nicotine dependence. Treatment outcome methodology will be combined with a computerized self-monitoring methodology to examine the extent to which smoking serves as a cue for alcohol craving and/or as a response to alcohol craving in treated alcoholics. Subjects will be veterans participating in the Substance Abuse Day Programs at the Newington and West Haven campuses of the VA Connecticut Healthcare System. Nonveteran women will be recruited from the community and enrolled in the day program. Subjects will be randomly assigned to one of the following two conditions: (1) intensive smoking cessation therapy (counseling plus nicotine replacement using nicotine patches) concurrent with alcohol treatment, or (2) brief smoking cessation advice concurrent with alcohol treatment.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Concurrent Alcohol and Smoking Treatment: Effects on Alcohol Relapse Risk

NCT00861146

Tobacco Use Cessation Alcohol-related Disorders

COMPLETED PHASE2

Behavioral Counseling for Alcohol Dependent Smokers (Nicotine Patch)

NCT00004551

Alcoholism Smoking

COMPLETED PHASE4

Smoking Cessation in Alcoholics

NCT00963482

Smoking Cessation Alcohol Consumption

COMPLETED NA

Mobile Contingency Management for Concurrent Abstinence From Alcohol and Smoking

NCT02995915

Smoking Cessation Alcohol Drinking

COMPLETED PHASE4

Alcohol Counseling for Telephone Quitline Callers

NCT01120080

Smoking Nicotine Dependence Alcohol Dependence

COMPLETED PHASE1/PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Alcoholism Smoking

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

nicotine replacement patch

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Meets criteria for alcohol dependence within the past three months, and criteria for nicotine dependence.
* Smoking at least 10 or more cigarettes per day for the past year.
* Seeking treatment for both alcohol and nicotine dependence.
* Minimum 1 week of alcohol abstinence and substance abuse day treatment attendance.
* Willing to provide names of two individuals who can help locate the subject at follow-up.
* Willing to provide name of one individual who can provide collateral information about alcohol and tobacco use.

Exclusion Criteria

* Other substance use disorder meeting criteria for dependence.
* Acute medical or psychiatric disorder requiring inpatient treatment.
* Taking medications known to influence alcohol urges (naltrexone, disulfiram).
* Medical problems that would contraindicate nicotine patch use.
* Allergy or hypersensitivity to nicotine or to adhesives used in transdermal delivery systems.
* Use of other nicotine products such as cigars, pipes, or smokeless tobacco.
* Severe generalized skin disorder.
* Myocardial infarction within 3 months prior to study entry.
* Unstable angina.
* Pregnant or lactating females, or females who are not practicing a medically accepted form of contraception.
* Impaired vision or hearing which would interfere with using a hand-held computer.
* Reading ability below fifth grade level.
* Lack of reliable transportation to the treatment site, or living more than 1 hour from treatment site.
* Homeless or unstable residence.
* Plan for future admission to residential treatment.

Minimum Eligible Age

21 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No